+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Lipid-Based Pharma Excipients Market - Global Outlook & Forecast 2025-2030

  • PDF Icon

    Report

  • 432 Pages
  • March 2025
  • Region: Global
  • Arizton
  • ID: 6058401
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Lipid-Based Pharma Excipients Market was valued at USD 953.01 million in 2024, and is projected to reach USD 1.32 billion by 2030, rising at a CAGR of 5.63%.

MARKET TRENDS & DRIVERS

Shift Toward Natural and Biodegradable Lipid Excipients

The pharmaceutical industry is undergoing a paradigm shift, accounting for increased attention to sustainability and biocompatibility. In this context, the global lipid-based pharma excipients market is embracing a transition toward natural and biodegradable lipid excipients. This trend is opening doors to innovative growth avenues by catering to the consumer demand for greener alternatives, the regulatory pressure for environment-friendly products, and the advancements in pharmaceutical formulations. Several key factors are contributing to the growing interest in natural and biodegradable lipid excipients in the pharmaceutical industry. For instance, consumers are increasingly favoring sustainable and environmentally conscious pharmaceutical products. The demand for clean-label medications, driven by the same consumer trends influencing food and cosmetics, is accelerating the adoption of natural excipients derived from plant sources. Moreover, governments and regulatory bodies worldwide are pushing for the adoption of sustainable and biodegradable materials in the pharmaceutical sector. Compliance with environmental regulations, such as the European Green Deal and similar initiatives, is incentivizing manufacturers to transition to biodegradable excipients.

Advancements in Lipid Nanoparticles and Drug Delivery Systems

The pharmaceutical industry has witnessed remarkable advancements in drug delivery systems over the past decade, with lipid nanoparticles (LNPs) emerging as one of the most promising technologies. Lipid-based formulations, particularly LNPs, have gained significant attention due to their ability to enhance the stability, bioavailability, and targeted delivery of therapeutics. This technological evolution is creating substantial opportunities for the global lipid-based pharma excipients market, driven by the growing demand for innovative drug delivery solutions. The advancements in lipid nanoparticles are driving the demand for high-quality lipid-based excipients. These excipients, including phospholipids, triglycerides, and cholesterol, are integral to the stability and functionality of LNP formulations.

Advancements in Lipid Processing Technologies

The pharmaceutical industry is undergoing rapid transformation, with an increasing emphasis on advanced drug delivery systems. Lipid-based excipients have become essential components in the formulation of poorly water-soluble drugs due to their ability to improve bioavailability and stability. The advancements in lipid processing technologies, such as spray drying, melt extrusion, and co-crystallization, have revolutionized the production and application of lipid-based excipients. These new technologies address key challenges in drug formulation, driving the lipid-based pharma excipients market growth and enabling pharmaceutical manufacturers to meet the growing demand for sophisticated drug delivery solutions. Moreover, the production and optimization of lipid-based excipients require advanced processing techniques to ensure consistent quality, stability, and performance. Traditional lipid processing methods often face limitations such as poor extensibility, low encapsulation efficiency, and difficulty in controlling particle size. The recent advancements in lipid processing technology have overcome these limitations, paving the way for the development of advanced excipients and drug formulations.

Rising Consumer Demand for Oral and Topical Formulations

The global pharmaceutical industry is witnessing a significant shift toward patient-friendly drug delivery systems, with oral and topical dosage forms gaining popularity among consumers. This growing demand is driving the expansion of the lipid-based pharma excipients market. As pharmaceutical companies increasingly focus on patient-centric drug development, the use of lipid excipients in oral and topical drug delivery is gaining importance. Moreover, oral and topical drug delivery systems have gained immense popularity due to their ease of administration, better patient compliance, and non-invasive nature.

Growth of Biopharmaceuticals and mRNA-Based Therapies

The rapid advancements in biopharmaceuticals and mRNA-based therapies have fueled the demand for specialized drug delivery systems, leading to significant growth in the lipid-based pharma excipients market. Lipid-based excipients, including phospholipids, glycerides, and sterols, play a critical role in drug solubility, stability, and bioavailability, making them essential components in modern drug formulation. Moreover, biopharmaceuticals, including monoclonal antibodies, gene therapies, and cell-based treatments, have emerged as the dominant force in the pharmaceutical industry. With biologics accounting for over 40% of new drug approvals globally, the demand for lipid-based excipients has surged due to their ability to enhance drug absorption and stability. The growing prevalence of chronic diseases such as cancer, autoimmune disorders, and rare genetic conditions has further accelerated biopharmaceutical development, directly benefiting lipid-excipient manufacturers.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

The global lipid-based pharma excipients market by product type is segmented into fats, phospholipids, oils, waxes, and others. Fats are a vital component of the market, holding the most significant segment share and playing a significant role in enhancing drug solubility, stability, and controlled release. Their applications span oral, injectable, and topical formulations, contributing to improved bioavailability and patient compliance. With the rising demand for lipid-based drug delivery systems, biologics, and personalized medicine, the market for fat-based pharma excipients is poised for substantial growth in the future. Moreover, phospholipids are a vital category of the lipid-based pharma excipients market, offering unique advantages in drug solubility, stability, and targeted delivery. Their ability to form self-assembled nanostructures makes them essential for modern drug formulation strategies, including liposomes, emulsions, and lipid nanoparticles. As research progresses, phospholipids will continue to play a pivotal role in developing innovative and efficient drug delivery systems.

Segmentation by Product Type

  • Fats
  • Phospholipids
  • Oils
  • Waxes
  • Others

INSIGHTS BY FUNCTIONALITY

The global lipid-based pharma excipients market by functionality is segmented into solubilizers & wetting agents, emulsifiers & surfactants, structuring agents & lubricants, emollients, penetration enhancers and solvents, and others. The solubilizers & wetting agents segment holds the most significant market share. In pharmaceutical formulations, excipients play a critical role in enhancing drug performance, stability, and bioavailability. Among these, lipid-based excipients have gained prominence due to their ability to improve the solubility and dispersion of poorly water-soluble drugs. Two of their key functionalities are their use as solubilizers and wetting agents, which are crucial in optimizing drug delivery and therapeutic efficacy. Also, many active pharmaceutical ingredients (APIs) suffer from poor aqueous solubility, leading to low bioavailability when administered orally. Lipid-based excipients act as solubilizers by incorporating these hydrophobic drugs into lipid structures, thereby enhancing their dissolution and absorption in the gastrointestinal (GI) tract.

Segmentation by Functionality

  • Solubilizers & Wetting Agents
  • Emulsifiers & Surfactants
  • Structuring Agents & Lubricants
  • Emollients, Penetration Enhancers, & Solvents
  • Others

INSIGHTS BY FORMULATION

The global lipid-based pharma excipients market by formulation is segmented into enteral, injectables, and topical. The enteral segment holds the most prominent share of the global market in 2024. Lipid-based pharma excipients play a crucial role in enteral drug formulations, which include oral and rectal dosage forms such as solid orals, liquid orals, suppositories, and pessaries. Lipid-based excipients are used in various enteral formulations to optimize drug solubility, absorption, and therapeutic efficacy. These excipients include fatty acids, triglycerides, phospholipids, emulsifiers, and waxes, which serve different functional roles depending on the type of formulation.

Segmentation by Formulation

  • Enteral
  • Injectables
  • Topical

INSIGHTS BY END-USER

The pharma & biotech companies by end-user hold the most significant share of the global lipid-based pharma excipients market. In pharmaceutical productions, lipid excipients have become popular and are now largely used to enhance the solubility of active ingredients. Lipid-based formulations allow increasing bioavailability of lipophilic active ingredients that would otherwise be poorly water-soluble. These factors are essential for oral formulations in pharmaceutical production. Pharma & biotech companies drive the highest demand for lipid-based excipients due to increasing production capacity, rising competition for market penetration, goals to deliver the highest-quality products, and stay competent with achieving the highest volume and revenue across the industry. Furthermore, CMOs are the second largest revenue contributor in the global lipid-based pharma excipients market. During the forecast period 2024-2030, the CMOs segment is expected to grow with the highest CAGR of 6.27%. CMOs have become the cornerstone of pharmaceutical manufacturing. Small & mid-sized, and large pharma companies are rapidly turning towards CMOs as they offer cost-effective contract manufacturing services.

Segmentation by End-User

  • Pharma & Biotech Companies
  • Contract Manufacturing Organizations (CMOs)
  • Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)
  • Academic & Research Institutes

GEOGRAPHICAL ANALYSIS

The global lipid-based pharma excipients market is expanding rapidly, driven by the growing demand for lipid-based drug delivery systems, the increased adoption of lipid nanoparticles in vaccines, and advancements in drug solubility enhancement technologies. North America, particularly the U.S. and Canada, holds a dominant position in the lipid-based pharma excipients market. The region benefits from a well-established pharmaceutical industry, strong R&D capabilities, and a high level of regulatory compliance. Furthermore, the U.S. is home to major pharmaceutical giants, such as Pfizer, Merck, and Moderna, which extensively use lipid-based excipients in drug formulations, including lipid nanoparticles for mRNA vaccines.

Europe is another major player in the global lipid-based pharma excipients market, with key countries including Germany, Switzerland, Ireland, Belgium, Italy, and the UK. The region is known for its focus on high-quality and sustainably sourced lipid excipients as well as strong pharmaceutical manufacturing capabilities. Furthermore, APAC is experiencing the fastest growth in the lipid-based pharma excipients market, with key contributors including China, Japan, India, South Korea, and Australia. This growth is fueled by rising pharmaceutical manufacturing, increasing investments in drug delivery technologies, and cost-effective production.

Latin America is an emerging lipid-based pharma excipients market, with key countries including Brazil, Mexico, Argentina, and Colombia. The region is witnessing increased pharmaceutical production, particularly in generic drugs and contract manufacturing. The region is home to a rapidly expanding generic drug market, and lipid-based excipients play a crucial role in the formulation of generic and innovative drugs, especially those requiring improved bioavailability. Furthermore, the Middle East & Africa region represents a nascent but growing lipid-based pharma excipients market. The key countries driving demand include Turkey, Saudi Arabia, the UAE, and South Africa. The market is supported by increasing investments in pharmaceutical production and healthcare infrastructure. Also, the region's expanding population and improving healthcare systems are increasing the need for advanced drug formulations.

Segmentation by Geography

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • Switzerland
    • Ireland
    • Belgium
    • Italy
    • France
    • Netherlands
    • The U.K.
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia
    • UAE

COMPETITIVE LANDSCAPE

The global lipid-based pharmaceutical excipients market has witnessed considerable growth in recent years, driven by increasing demand for novel drug delivery systems and the growing need for high-quality excipients to improve drug formulation. Lipid-based excipients, such as solid lipid nanoparticles, liposomes, and lipid emulsions, play a crucial role in enhancing the bioavailability, stability, and targeted delivery of poorly soluble drugs. As the demand for such excipients continues to rise, the competition in the lipid-based pharma excipients market has intensified, with several global players striving to gain a larger market share by offering innovative solutions and establishing strategic partnerships.

Innovation is at the forefront of the competitive strategies of many players in the lipid-based excipients market. Companies in the lipid-based pharma excipients market are focusing on developing new lipid formulations, enhancing existing products, and exploring novel drug delivery systems. For example, advancements in lipid nanoparticles and liposomes for drug encapsulation are driving growth in the lipid-based pharma excipients market. Significant R&D investments are critical to staying ahead in the competitive landscape. Players like BASF and Lonza are constantly upgrading their product offerings to cater to emerging market needs. Furthermore, collaboration with other pharmaceutical and biotechnology firms is another key strategy for growth. Companies in the lipid-based pharma excipients market often form partnerships with drug manufacturers to develop specialized formulations for specific therapeutic areas. Additionally, acquisitions play a vital role in strengthening product portfolios and expanding market reach. Evonik Industries, for example, has expanded its presence through strategic acquisitions in the biopharmaceutical and excipient sectors.

Key Vendors

  • ABF Ingredients - ABITEC
  • BASF
  • Croda International
  • Gattefosé
  • IOI Oleo GMbH
  • Merck KGaA

Other Prominent Vendors

  • AAK
  • Alsiano
  • Biopharma PEG Scientific
  • CD Formulation
  • CLARIANT
  • Colorcon
  • CordenPharma
  • CREMER OLEO
  • Evonik
  • Kao Corporation
  • Lipoid
  • NOF CORPORATION
  • Pothe Hille & Co
  • The East Africa Wax Company
  • VAV Life Sciences (VAV)
  • WAXOILS

KEY QUESTIONS ANSWERED

1. How big is the global lipid-based pharma excipients market?
2. What is the growth rate of the global lipid-based pharma excipients market?
3. Which region dominates the global lipid-based pharma excipients market share?
4. Who are the key players in the global lipid-based pharma excipients market?
5. What are the significant trends in the lipid-based pharma excipients industry?

Table of Contents

1. Scope & Coverage
1.1. Market Definition
1.1.1. Inclusions
1.1.2. Exclusions
1.1.3. Market Estimation Caveats
1.2. Market Segmentation Coverage & Definitions
1.2.1. Product Type
1.2.2. Functionality
1.2.3. Formulation
1.2.4. End-user
1.3. Market Derivation
2. Premium Insights
2.1. Overview
2.2. Opportunity Pockets
3. Market at a Glance
4. Introduction
4.1. Overview
4.1.1. Key Customer Demands from Drug Producers
4.1.2. Value Chain Developments
5. Market Opportunities & Trends
5.1. Growing Significance of Co-Processed Excipients
5.2. Expanding Use of Lipid Excipients in Combination Therapies
5.3. Growing Development of Long-Acting Injectable (Lai) Depot Formulations
5.4. Growing Emphasis on Development of Multifunctional Lipid-Excipients
5.5. Shift Toward Natural and Biodegradable Lipid Excipients
5.6. Advancements in Lipid Nanoparticles and Drug Delivery Systems
6. Market Growth Enablers
6.1. Advancements in Lipid Processing Technologies
6.2. Rising Consumer Demand for Oral and Topical Formulations
6.3. Growth of Biopharmaceuticals and Mrna-based Therapies
6.4. Favorable Governement Initiatives
6.5. Growth in Self-Emulsifying Drug Delivery System (Sedds)
6.6. Growing Focus on Biologics Spurring Increased Investments in Biologic Excipients
7. Market Restraints
7.1. Supply Chain & Raw Material Sourcing Issues
7.2. Availability of Alternative Pharma Excipients
7.3. Complex Manufacturing and Processing of Lipid Excipients
7.4. Regulatory and Quality Concerns
8. Market Landscape
8.1. Market Overview
8.2. Market Size & Forecast
8.3. Five Forces Analysis
8.3.1. Threat of New Entrants
8.3.2. Bargaining Power of Suppliers
8.3.3. Bargaining Power of Buyers
8.3.4. Threat of Substitutes
8.3.5. Competitive Rivalry
9. Product Type
9.1. Market Snapshot & Growth Engine
9.2. Market Overview
9.3. Fats
9.3.1. Market Overview
9.3.2. Market Size & Forecast
9.3.3. Market by Geography
9.4. Phospholipids
9.4.1. Market Overview
9.4.2. Market Size & Forecast
9.4.3. Market by Geography
9.5. Oils
9.5.1. Market Overview
9.5.2. Market Size & Forecast
9.5.3. Market by Geography
9.6. Waxes
9.6.1. Market Overview
9.6.2. Market Size & Forecast
9.6.3. Market by Geography
9.7. Others
9.7.1. Market Overview
9.7.2. Market Size & Forecast
9.7.3. Market by Geography
10. Functionality
10.1. Market Snapshot & Growth Engine
10.2. Market Overview
10.3. Solubilizers & Wetting Agents
10.3.1. Market Overview
10.3.2. Market Size & Forecast
10.3.3. Market by Geography
10.4. Emulsifier & Surfactant
10.4.1. Market Overview
10.4.2. Market Size & Forecast
10.4.3. Market by Geography
10.5. Structuring Agents & Lubricants
10.5.1. Market Overview
10.5.2. Market Size & Forecast
10.5.3. Market by Geography
10.6. Emollients, Penetration Enhancers, & Solvents
10.6.1. Market Overview
10.6.2. Market Size & Forecast
10.6.3. Market by Geography
10.7. Others
10.7.1. Market Overview
10.7.2. Market Size & Forecast
10.7.3. Market by Geography
11. Formulation
11.1. Market Snapshot & Growth Engine
11.2. Market Overview
11.3. Enteral
11.3.1. Market Overview
11.3.2. Market Size & Forecast
11.3.3. Market by Geography
11.4. Injectables
11.4.1. Market Overview
11.4.2. Market Size & Forecast
11.4.3. Market by Geography
11.5. Topical
11.5.1. Market Overview
11.5.2. Market Size & Forecast
11.5.3. Market by Geography
12. End-users
12.1. Market Snapshot & Growth Engine
12.2. Market Overview
12.3. Pharma & Biotech Companies
12.3.1. Market Overview
12.3.2. Market Size & Forecast
12.3.3. Market by Geography
12.4. Contract Manufacturing Organizations (Cmos)
12.4.1. Market Overview
12.4.2. Market Size & Forecast
12.4.3. Market by Geography
12.5. Contract Research Organizations & Contract Development and Manufacturing Organizations (Cros & Cdmos)
12.5.1. Market Overview
12.5.2. Market Size & Forecast
12.5.3. Market by Geography
12.6. Academic & Research Institute
12.6.1. Market Overview
12.6.2. Market Size & Forecast
12.6.3. Market by Geography
13. Geography
13.1. Market Snapshot & Growth Engine
13.2. Geographic Overview
14. North America
14.1. Market Overview
14.2. Market Size & Forecast
14.2.1. Product Type
14.2.2. Functionality
14.2.3. Formulation
14.2.4. End-user
14.3. Key Countries
14.3.1. US: Market Size & Forecast
14.3.2. Canada: Market Size & Forecast
15. Europe
15.1. Market Overview
15.2. Market Size & Forecast
15.2.1. Product Type
15.2.2. Functionality
15.2.3. Formulation
15.2.4. End-user
15.3. Key Countries
15.3.1. Germany: Market Size & Forecast
15.3.2. Switzerland: Market Size & Forecast
15.3.3. Ireland: Market Size & Forecast
15.3.4. Belgium: Market Size & Forecast
15.3.5. Italy: Market Size & Forecast
15.3.6. France: Market Size & Forecast
15.3.7. Netherlands: Market Size & Forecast
15.3.8. UK: Market Size & Forecast
15.3.9. Spain: Market Size & Forecast
16. APAC
16.1. Market Overview
16.2. Market Size & Forecast
16.2.1. Product Type
16.2.2. Functionality
16.2.3. Formulation
16.2.4. End-user
16.3. Key Countries
16.3.1. China: Market Size & Forecast
16.3.2. Japan: Market Size & Forecast
16.3.3. India: Market Size & Forecast
16.3.4. South Korea: Market Size & Forecast
16.3.5. Australia: Market Size & Forecast
17. Latin America
17.1. Market Overview
17.2. Market Size & Forecast
17.2.1. Product Type
17.2.2. Functionality
17.2.3. Formulation
17.2.4. End-user
17.3. Key Countries
17.3.1. Brazil: Market Size & Forecast
17.3.2. Mexico: Market Size & Forecast
17.3.3. Argentina: Market Size & Forecast
17.3.4. Colombia: Market Size & Forecast
18. Middle East & Africa
18.1. Market Overview
18.2. Market Size & Forecast
18.2.1. Product Type
18.2.2. Functionality
18.2.3. Formulation
18.2.4. End-user
18.3. Key Countries
18.3.1. Turkey: Market Size & Forecast
18.3.2. South Africa: Market Size & Forecast
18.3.3. Saudi Arabia: Market Size & Forecast
18.3.4. UAE: Market Size & Forecast
19. Competitive Landscape
19.1. Competition Overview
19.2. Market Share Analysis
19.2.1. Basf
19.2.2. Abitec
19.2.3. Merck KGaA
19.2.4. Gattefossé
19.2.5. Croda International
19.2.6. Ioi Oleo GmbH
20. Key Company Profiles
20.1. Abf Ingredients - Abitec
20.1.1. Business Overview
20.1.2. Product Offerings
20.1.3. Key Strategies
20.1.4. Key Strengths
20.1.5. Key Opportunities
20.2. Basf
20.2.1. Business Overview
20.2.2. Product Offerings
20.2.3. Key Strategies
20.2.4. Key Strengths
20.2.5. Key Opportunities
20.3. Croda International
20.3.1. Business Overview
20.3.2. Product Offerings
20.3.3. Key Strategies
20.3.4. Key Strengths
20.3.5. Key Opportunities
20.4. Gattefosé
20.4.1. Business Overview
20.4.2. Product Offerings
20.4.3. Key Strategies
20.4.4. Key Strengths
20.4.5. Key Opportunities
20.5. Ioi Oleo GmbH
20.5.1. Business Overview
20.5.2. Product Offerings
20.5.3. Key Strategies
20.5.4. Key Strengths
20.5.5. Key Opportunities
20.6. Merck KGaA
20.6.1. Business Overview
20.6.2. Product Offerings
20.6.3. Key Strategies
20.6.4. Key Strengths
20.6.5. Key Opportunities
21. Other Prominent Vendors
21.1. Aak
21.1.1. Business Overview
21.1.2. Product Offerings
21.2. Alsiano
21.2.1. Business Overview
21.2.2. Product Offerings
21.3. Biopharma Peg Scientific
21.3.1. Business Overview
21.3.2. Product Offerings
21.4. Cd Formulation
21.4.1. Business Overview
21.4.2. Product Offerings
21.5. Clariant
21.5.1. Business Overview
21.5.2. Product Offerings
21.6. Colorcon
21.6.1. Business Overview
21.6.2. Product Offerings
21.7. Cordenpharma
21.7.1. Business Overview
21.7.2. Product Offerings
21.8. Cremer Oleo
21.8.1. Business Overview
21.8.2. Product Offerings
21.9. Evonik
21.9.1. Business Overview
21.9.2. Product Offerings
21.10. Kao Corporation
21.10.1. Business Overview
21.10.2. Product Offerings
21.11. Lipoid
21.11.1. Business Overview
21.11.2. Product Offerings
21.12. Nof Corporation
21.12.1. Business Overview
21.12.2. Product Offerings
21.13. Poth Hille & Co
21.13.1. Business Overview
21.13.2. Product Offerings
21.14. the East Africa Wax Company
21.14.1. Business Overview
21.14.2. Product Offerings
21.15. Vav Life Sciences (Vav)
21.15.1. Business Overview
21.15.2. Product Offerings
21.16. Waxoils
21.16.1. Business Overview
21.16.2. Product Offerings
22. Report Summary
22.1. Key Takeaways
22.2. Strategic Recommendations
23. Quantitative Summary
23.1. Market by Geography
23.1.1. Fats
23.1.2. Phospholipids
23.1.3. Oils
23.1.4. Waxes
23.1.5. Others
23.1.6. Solubilizers & Wetting Agents
23.1.7. Emulsifier & Surfactunt
23.1.8. Structuring Agents & Lubricants
23.1.9. Emollients, Penetration Enhancers, & Solvents
23.1.10. Others
23.1.11. Enteral
23.1.12. Injectables
23.1.13. Topical
23.1.14. Pharma & Biotech Companies
23.1.15. Cmos
23.1.16. Cros & Cdmos
23.1.17. Acdemic & Research Institutes
23.2. Market by Product Type
23.2.1. North America
23.2.2. Europe
23.2.3. APAC
23.2.4. Latin America
23.2.5. Middle East & Africa
23.3. Market by Functionality
23.3.1. North America
23.3.2. Europe
23.3.3. APAC
23.3.4. Latin America
23.3.5. Middle East & Africa
23.4. Market by Formulation
23.4.1. North America
23.4.2. Europe
23.4.3. APAC
23.4.4. Latin America
23.4.5. Middle East & Africa
23.5. Market by End-user
23.5.1. North America
23.5.3. Europe
23.5.5. APAC
23.5.7. Latin America
23.5.9. Middle East & Africa
24. Appendix
24.1. Research Methodology
24.2. Research Process
24.3. Report Assumptions & Caveats
24.3.1. Key Caveats
24.3.2. Currency Conversion
24.4. Abbreviations
List of Exhibits
Exhibit 1 Market Size Calculation Approach 2024
Exhibit 2 Impact of Growing Significance of Co-Processed Excipients
Exhibit 3 Impact of Expanding Use of Lipid Excipients in Combination Therapies
Exhibit 4 Impact of Growing Development of Long-Acting Injectable (Lai) Depot Formulations
Exhibit 5 Impact of Growing Emphasis on Development of Multifunctional Lipid-Excipients
Exhibit 6 Impact of Shift Toward Natural and Biodegradable Lipid Excipients
Exhibit 7 Impact of Advancements in Lipid Nanoparticles and Drug Delivery Systems
Exhibit 8 Impact of Advancements in Lipid Processing Technologies
Exhibit 9 Impact of Rising Consumer Demand for Oral and Topical Formulations
Exhibit 10 Impact of Growth of Biopharmaceuticals and Mrna-based Therapies
Exhibit 11 Impact of Favorable Government Initiatives
Exhibit 12 Impact of Growth in Self-Emulsifying Drug Delivery System (Sedds)
Exhibit 13 Impact of the Growing Focus on Biologics Spurring Increased Investments in Biologic Excipients
Exhibit 14 Impact of Supply Chain & Raw Material Sourcing Issues
Exhibit 15 Impact of Availability of Alternative Pharma Excipients
Exhibit 16 Impact of the Complex Manufacturing and Processing of Lipid Excipients
Exhibit 17 Impact of Regulatory and Quality Concerns
Exhibit 18 Global Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 19 Five Forces Analysis 2024
Exhibit 20 Incremental Growth by Product Type 2024 & 2030
Exhibit 21 Global Lipid-based Pharma Excipients Market by Product Type 2024-2030: Incremental Growth ($ Million)
Exhibit 22 Global Lipid-based Pharma Excipients Market by Product Type 2024-2030: Absolute Growth (%)
Exhibit 23 Global Fat-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 24 Global Fat-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 25 Global Phospholipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 26 Global Phospholipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 27 Global Oil-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 28 Global Oil-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 29 Global Waxes-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 30 Global Waxes-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 31 Global Other Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 32 Global Other Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 33 Incremental Growth by Functionality 2024 & 2030
Exhibit 34 Global Lipid-based Pharma Excipients Market by Functionality 2024-2030: Incremental Growth ($ Million)
Exhibit 35 Global Lipid-based Pharma Excipients Market by Functionality 2024-2030: Absolute Growth (%)
Exhibit 36 Global Solubilizers & Wetting Agents Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 37 Global Solubilizers & Wetting Agents Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 38 Global Emulsifier & Surfactant Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 39 Global Emulsifier & Surfactant Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 40 Global Structuring Agents & Lubricants Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 41 Global Structuring Agents & Lubricants Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 42 Global Emollients, Penetration Enhancers, & Solvents Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 43 Global Emollients, Penetration Enhancers, & Solvents Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 44 Global Others Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 45 Global Other Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 46 Incremental Growth by Formulation 2024 & 2030
Exhibit 47 Global Lipid-based Pharma Excipients Market by Formulation 2024-2030: Incremental Growth ($ Million)
Exhibit 48 Global Lipid-based Pharma Excipients Market by Formulation 2024-2030: Absolute Growth (%)
Exhibit 49 Global Enteral Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 50 Global Enteral Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 51 Global Injectables Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 52 Global Injectables Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 53 Global Topical Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 54 Global Topical Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 55 Incremental Growth by End-user 2024 & 2030
Exhibit 56 Global Lipid-based Pharma Excipients Market by End-user 2024-2030: Incremental Growth ($ Million)
Exhibit 57 Global Lipid-based Pharma Excipients Market by End-user 2024-2030: Absolute Growth (%)
Exhibit 58 Global Pharma & Biotech Companies Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 59 Global Pharma & Biotech Companies Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 60 Global Cmos Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 61 Global Cmos Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 62 Global Cros and Cdmos Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 63 Global Cros & Cdmos Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 64 Global Academic & Research Institutes Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 65 Global Academic & Research Institutes Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 66 Incremental Growth by Geography 2024 & 2030
Exhibit 67 Global Lipid-based Pharma Excipients Market by Geography 2024-2030: Incremental Growth ($ Million)
Exhibit 68 Global Lipid-based Pharma Excipients Market by Geography 2024-2030: Absolute Growth (%)
Exhibit 69 North America Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 70 North America Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 71 Incremental Growth in North America 2024 & 2030
Exhibit 72 US Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 73 Canada Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 74 Europe Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 75 Europe Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 76 Incremental Growth in Europe 2024 & 2030
Exhibit 77 Germany Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 78 Switzerland Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 79 Ireland Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 80 Belgium Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 81 Italy Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 82 France Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 83 Netherlands Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 84 UK Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 85 Spain Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 86 APAC Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 87 APAC Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 88 Incremental Growth in APAC 2024 & 2030
Exhibit 89 China Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 90 Japan Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 91 India Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 92 South Korea Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 93 Australia Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 94 Latin America Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 95 Latin America Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 96 Incremental Growth in Latin America 2024 & 2030
Exhibit 97 Brazil Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 98 Mexico Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 99 Argentina Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 100 Colombia Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 101 Middle East & Africa Lipid-based Pharma Excipients Market 2024-2030: Incremental & Absolute Growth
Exhibit 102 Middle East & Africa Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 103 Incremental Growth in Middle East & Africa 2024 & 2030
Exhibit 104 Turkey Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 105 South Africa Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 106 Saudi Arabia Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 107 UAE Lipid-based Pharma Excipients Market 2021-2030 ($ Million)
Exhibit 108 Competitors for Lipid-based Pharma Excipient Manufacturer
Exhibit 109 Lipid-based Pharma Excipients Market Share Analysis (%)
Exhibit 110 Abf Ingredients Annual Revenue 2021-2023 ($ Billion)
Exhibit 111 Basf Annul Report 2021-2023 ($ Billion)
Exhibit 112 Croda International Annual Revenue 2021-2023 ($ Million)
Exhibit 113 Croda International Annual Revenue by Business Segments 2023 (%)
Exhibit 114 Croda International Annual Revenue by Geography 2023 (%)
Exhibit 115 Merck KGaA Annual Revenue 2021-2023 ($ Billion)
Exhibit 116 Merck KGaA Annual Revenue by Business Segment 2023 (%)
Exhibit 117 Key Caveats
List of Tables
Table 1 Some Fat-based Excipients for Pharmaceutical Excipients
Table 2 Global Fat-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 3 Global Fat-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 4 Classification and Source of Phospholipids
Table 5 Phospholipid Delivery Format, Dosage Form, and Recommendation in Pharmaceutical Formulations
Table 6 Global Phospholipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 7 Global Phospholipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 8 Classification and Source of Lipid Oils for Pharmaceutical Applications
Table 9 Global Oil-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 10 Global Oil-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 11 Some Companies Offering Lipid Waxes in Pharmaceutical Formulations
Table 12 Global Waxes-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 13 Global Waxes-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 14 Examples of Steroid-based Pharma Excipients
Table 15 Examples of Sphingolipid-based Pharma Excipients
Table 16 Global Other Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 17 Global Other Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 18 Global Solubilizers & Wetting Agents Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 19 Global Solubilizers & Wetting Agents Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 20 Global Emulsifier & Surfactant Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 21 Global Emulsifier & Surfactant Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 22 Global Structuring Agents & Lubricants Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 23 Global Structuring Agents & Lubricants Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 24 Global Emollients, Penetration Enhancers, & Solvents Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 25 Global Emollients, Penetration Enhancers, & Solvents Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 26 Global Other Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 27 Global Other Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 28 Global Enteral Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 29 Global Enteral Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 30 Global Injectables Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 31 Global Injectables Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 32 Global Topical Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 33 Global Topical Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 34 List of Top Pharmaceutical Manufacturing Companies by Geographies 2025
Table 35 Global Pharma & Biotech Companies Lipid-based Excipients Market by Geography 2024-2030 ($ Million)
Table 36 Global Pharma & Biotech Companies Lipid-based Excipients Market by Geography 2024-2030 (%)
Table 37 List of Top Contract Manufacturing Organization
Table 38 Global Cmos Lipid-based Excipients Market by Geography 2024-2030 ($ Million)
Table 39 Global Cmos Lipid-based Excipients Market by Geography 2024-2030 (%)
Table 40 List of Some Leading Contract Research Organization (Global).
Table 41 List of Some Leading Global Cdmos: a Potential Buyer for Lipid-based Excipients
Table 42 Global Cros & Cdmos Lipid-based Excipients Market by Geography 2024-2030 ($ Million)
Table 43 Global Cros & Cdmos Lipid-based Excipients Market by Geography 2024-2030 (%)
Table 44 Global Academic & Research Institutes Lipid-based Excipients Market by Geography 2024-2030 ($ Million)
Table 45 Global Academic & Research Institutes Lipid-based Excipients Market by Geography 2024-2030 (%)
Table 46 North America Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 47 North America Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 48 North America Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 49 North America Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 50 North America Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 51 North America Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 52 North America Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 53 North America Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 54 Top States and Territories in Exports for Pharmaceutical and Medicine Manufacturing, 2023
Table 55 Europe Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 56 Europe Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 57 Europe Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 58 Europe Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 59 Europe Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 60 Europe Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 61 Europe Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 62 Europe Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 63 APAC Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 64 APAC Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 65 APAC Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 66 APAC Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 67 APAC Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 68 APAC Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 69 APAC Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 70 APAC Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 71 Latin America Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 72 Latin America Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 73 Latin America Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 74 Latin America Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 75 Latin America Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 76 Latin America Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 77 Latin America Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 78 APAC Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 79 Middle East & Africa Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 80 Middle East & Africa Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 81 Middle East & Africa Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 82 Middle East & Africa Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 83 Middle East & Africa Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 84 Middle East & Africa Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 85 Middle East & Africa Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 86 Middle East & Africa Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 87 Abitec Corporation: Major Product Offerings
Table 88 Basf: Major Product Offerings
Table 89 Croda International: Major Product Offerings
Table 90 Gattefosé: Major Product Offerings
Table 91 Ioi Oleo GmbH: Major Product Offerings
Table 92 Merck KGaA: Major Product Offerings
Table 93 Aak: Major Product Offerings
Table 94 Alsiano: Major Product Offerings
Table 95 Biopharma Peg Scientific: Major Product Offerings
Table 96 Cd Formulation: Major Product Offerings
Table 97 Clariant: Major Product Offerings
Table 98 Colorcon: Major Product Offerings
Table 99 Cordenpharma: Major Product Offerings
Table 100 Cremer Oleo: Major Product Offerings
Table 101 Evonik: Major Product Offerings
Table 102 Kao Corporation: Major Product Offerings
Table 103 Lipoid: Major Product Offerings
Table 104 Nof Corporation1: Major Product Offerings
Table 105 Pothe Hille & Co: Major Product Offerings
Table 106 The East Africa Wax Company: Major Product Offerings
Table 107 Vav Life Sciences: Major Product Offerings
Table 108 Waxoils: Major Product Offerings
Table 109 Global Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 110 Global Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 111 Global Fat-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 112 Global Fat-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 113 Global Phospholipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 114 Global Phospholipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 115 Global Oil-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 116 Global Oil-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 117 Global Waxes-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 118 Global Waxes-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 119 Global Other Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 120 Global Other Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 121 Global Solubilizers & Wetting Agents Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 122 Global Solubilizers & Wetting Agents Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 123 Global Emulsifier & Surfactant Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 124 Global Emulsifier & Surfactant Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 125 Global Structuring Agents & Lubricants Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 126 Global Structuring Agents & Lubricants Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 127 Global Emollients, Penetration Enhancers, & Solvents Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 128 Global Emollients, Penetration Enhancers, & Solvents Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 129 Global Other Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 130 Global Other Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 131 Global Enteral Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 132 Global Enteral Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 133 Global Injectables Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 134 Global Injectables Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 135 Global Topical Lipid-based Pharma Excipients Market by Geography 2024-2030 ($ Million)
Table 136 Global Topical Lipid-based Pharma Excipients Market by Geography 2024-2030 (%)
Table 137 Global Pharma & Biotech Companies Lipid-based Excipients Market by Geography 2024-2030 ($ Million)
Table 138 Global Pharma & Biotech Companies Lipid-based Excipients Market by Geography 2024-2030 (%)
Table 139 Global Cmos Lipid-based Excipients Market by Geography 2024-2030 ($ Million)
Table 140 Global Cmos Lipid-based Excipients Market by Geography 2024-2030 (%)
Table 141 Global Cros & Cdmos Lipid-based Excipients Market by Geography 2024-2030 ($ Million)
Table 142 Global Cros & Cdmos Lipid-based Excipients Market by Geography 2024-2030 (%)
Table 143 Global Academic & Research Institutes Lipid-based Excipients Market by Geography 2024-2030 ($ Million)
Table 144 Global Academic & Research Institutes Lipid-based Excipients Market by Geography 2024-2030 (%)
Table 145 Global Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 146 Global Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 147 North America Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 148 North America Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 149 Europe Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 150 Europe Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 151 APAC Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 152 APAC Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 153 Latin America Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 154 Latin America Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 155 Middle East & Africa Lipid-based Pharma Excipients Market by Product Type 2024-2030 ($ Million)
Table 156 Middle East & Africa Lipid-based Pharma Excipients Market by Product Type 2024-2030 (%)
Table 157 Global Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 158 Global Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 159 North America Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 160 North America Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 161 Europe Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 162 Europe Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 163 APAC Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 164 APAC Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 165 Latin America Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 166 Latin America Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 167 Middle East & Africa Lipid-based Pharma Excipients Market by Functionality 2024-2030 ($ Million)
Table 168 Middle East & Africa Lipid-based Pharma Excipients Market by Functionality 2024-2030 (%)
Table 169 Global Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 170 Global Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 171 North America Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 172 North America Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 173 Europe Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 174 Europe Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 175 APAC Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 176 APAC Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 177 Latin America Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 178 Latin America Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 179 Middle East & Africa Lipid-based Pharma Excipients Market by Formulation 2024-2030 ($ Million)
Table 180 Middle East & Africa Lipid-based Pharma Excipients Market by Formulation 2024-2030 (%)
Table 181 Global Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 182 Global Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 183 North America Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 184 North America Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 185 Europe Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 186 Europe Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 187 APAC Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 188 APAC Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 189 Latin America Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 190 APAC Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 191 Middle East & Africa Lipid-based Pharma Excipients Market by End-user 2024-2030 ($ Million)
Table 192 Middle East & Africa Lipid-based Pharma Excipients Market by End-user 2024-2030 (%)
Table 193 Currency Conversion 2018-2024

Companies Mentioned

  • ABF Ingredients – ABITEC
  • BASF
  • Croda International
  • Gattefosé
  • IOI Oleo GMbH
  • Merck KGaA
  • AAK
  • Alsiano
  • Biopharma PEG Scientific
  • CD Formulation
  • CLARIANT
  • Colorcon
  • CordenPharma
  • CREMER OLEO
  • Evonik
  • Kao Corporation
  • Lipoid
  • NOF CORPORATION
  • Pothe Hille & Co
  • The East Africa Wax Company
  • VAV Life Sciences (VAV)
  • WAXOILS

Methodology


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...

Table Information